Amylyx Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AMLX on Nasdaq
Insider Sale
+$44,352
-2.16%
Shares
Shares Volume: 2,716 Shares
Average Share Price: $16.33
INSIDER
FRATES JAMES M
Chief Financial Officer (Officer)
reported on Jan 11 2024
traded on Jan 9 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 123,107 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $658,500.76 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 21 |
| P/S VALUE RATIO | 0.003 |
| AVERAGE SALE VALUE | $1,721,841.66 |
| COMPANY PREVIOUS TRADES |